Federated Hermes’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Federated Hermes’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-67,616	Closed	-$3.65M	–	2263
2017 Q3	$3.65M	Sell	67,616 -16,299	-19%	-$957K	0.01%	672
2017 Q2	$4.71M	Buy	83,915 +30,465	+57%	+$1.22M	0.01%	601
2017 Q1	$2.1M	Buy	+53,450	New	+$1.7M	0.01%	891
2014 Q1	–	Sell	-4,912	Closed	-$126K	–	1809
2013 Q4	$126K	Buy	+4,912	New	+$119K	﹤0.01%	1554

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

Federated Hermes's PTLA Position: Q4 2017 in Review

Federated Hermes sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2017, closing a stake of 67,616 shares — an estimated $3.65M sold.

Federated Hermes first reported a position in PTLA in Q4 2013 and held it in 4 quarters. The position peaked at $4.71M in Q2 2017. 215 funds tracked by Wall St. Rank hold PTLA as of Q4 2017.

Federated Hermes reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
Federated Hermes sold 67,616 Portola Pharmaceuticals, Inc. shares in Q4 2017, an estimated $3.65M.
Federated Hermes first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and held it in 4 quarters.
Federated Hermes's Portola Pharmaceuticals, Inc. position peaked at $4.71M in Q2 2017.
215 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2017.

Based on Federated Hermes's 13F filing for Q4 2017, filed 14 Feb 2018.